Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash Flows from Operating Activities:
Net income	$ 9,357	$ 9,841
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,874	1,957
Deferred income tax	2,341	575
Provision for bad debts	(593)	(1,140)
Stock issued for costs and expenses	1,955
(Increase) decrease in operating assets, net:
Accounts, medical receivable and management fee(s)	(2,309)	(1,492)
Notes receivable	(13)
Inventories	(225)	(71)
Prepaid expenses and other current assets	304	(74)
Other assets	2	(150)
Increase (decrease) in operating liabilities, net:
Accounts payable	(6)	(58)
Other current liabilities	(3,003)	(608)
Customer deposits	71	110
Other liabilities	21	(10)
Due to related medical practices	(135)
Net cash provided by operating activities	9,641	8,880
Cash Flows from Investing Activities:
Purchases of property and equipment	(2,238)	(1,862)
Cost of patents	(45)	(51)
Net cash used in investing activities	(2,283)	(1,913)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(15)	(99)
Additional acquisition costs		(58)
Distributions to noncontrolling interests	(3,690)	(2,760)
Repayment of notes receivable from employee stockholders		4
Net cash used in financing activities	(3,705)	(2,913)
Net Increase in Cash and Cash Equivalents	3,653	4,054
Cash and Cash Equivalents - Beginning of Period	19,634	10,140
Cash and Cash Equivalents - End of Period	$ 23,287	$ 14,194